Ann De Becker

4.0k total citations · 1 hit paper
75 papers, 2.6k citations indexed

About

Ann De Becker is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Ann De Becker has authored 75 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 19 papers in Genetics and 17 papers in Oncology. Recurrent topics in Ann De Becker's work include Mesenchymal stem cell research (12 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Multiple Myeloma Research and Treatments (8 papers). Ann De Becker is often cited by papers focused on Mesenchymal stem cell research (12 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Multiple Myeloma Research and Treatments (8 papers). Ann De Becker collaborates with scholars based in Belgium, United States and China. Ann De Becker's co-authors include Ivan Van Riet, Naoto Ueno, Roger Guillemin, Karin Vanderkerken, Song Xu, Shao‐Yao Ying, Nicholas Ling, Isabelle Vande Broek, Ben Van Camp and Ralph A. Gruppo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Ann De Becker

70 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?

2016 377 citations Ann De Becker, Ivan Van Riet World Journal of Stem Cells profile →

Peers

Countries citing papers authored by Ann De Becker

Since Specialization

Citations

This map shows the geographic impact of Ann De Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann De Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann De Becker more than expected).

Fields of papers citing papers by Ann De Becker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann De Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann De Becker. The network helps show where Ann De Becker may publish in the future.

Co-authorship network of co-authors of Ann De Becker

This figure shows the co-authorship network connecting the top 25 collaborators of Ann De Becker. A scholar is included among the top collaborators of Ann De Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann De Becker. Ann De Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real‐life data of luspatercept in lower‐risk myelodysplastic syndromes advocate new research objectives 2024 ·SHILAP Revista de lepidopterología ·(unknown), Stef Meers, (unknown), (unknown), Koen Theunissen, Koen Van Eygen, Nathan De Beule, (unknown), (unknown), (unknown), Jan Lemmens, Ann Van de Velde, Dominik Selleslag, Jason Bouziotis, Ann De Becker, Sébastien Anguille	0
2	AXL as immune regulator and therapeutic target in Acute Myeloid Leukemia: from current progress to novel strategies 2024 ·Experimental Hematology and Oncology ·(unknown), Nathan De Beule, Ann De Becker, Elke De Bruyne, Eline Menu, Karin Vanderkerken, Karine Breckpot, Nick Devoogdt, Kim De Veirman	4
3	The crosstalk between lung cancer and the bone marrow niche fuels emergency myelopoiesis 2024 ·Frontiers in Immunology ·(unknown), Kirsten De Ridder, (unknown), Yanina Jansen, (unknown), (unknown), Ann De Becker, Ivan Van Riet, Lore Decoster, Cleo Goyvaerts	1
4	Feasibility of co-transplantation of umbilical cord blood and third-party mesenchymal stromal cells after (non)myeloablative conditioning in patients with hematological malignancies 2024 ·Current Research in Translational Medicine ·(unknown), Ann De Becker, Tessa Kerre, Hélène Schoemans, Frédéric Baron, Carlos Graux, Ivan Van Riet, Chantal Lechanteur, Étienne Baudoux, Rik Schots, Yves Béguin	1
5	A single-cell transcriptomic map of the murine and human multiple myeloma immune microenvironment across disease stages 2024 ·Journal of Hematology & Oncology ·(unknown), Daliya Kancheva, (unknown), (unknown), Rong Fan, Pauline M. R. Bardet, (unknown), Kevin Verstaen, Ann De Becker, Karin Vanderkerken, Kim De Veirman, Damya Laoui	2
6	Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity 2024 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), Robin Maximilian Awad, (unknown), (unknown), Ann De Becker, Ivan Van Riet, Cleo Goyvaerts, Sandra Tuyaerts, Bart Neyns, Nick Devoogdt, Yannick De Vlaeminck, Karine Breckpot	7
7	Successful Treatment of Very Severe Sinusoidal Obstruction Syndrome After Gemtuzumab Ozogamicin With Transjugular Intrahepatic Portosystemic Shunt, Defibrotide, and High-Dose Corticosteroids: A Case Report 2024 ·Cureus ·(unknown), Nathan De Beule, F. van den Bergh, Pierre Lefesvre, Ann De Becker	1
8	Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases 2023 ·Journal of Autoimmunity ·Raffaella Greco, John A. Snowden, Nina Knelange, Gloria Tridello, (unknown), Aliénor Xhaard, Fabio Ciceri, Matthew Collin, Christelle Ferrá, Ann De Becker, Manuela Badoglio, Diana Averbuch, Tobias Alexander, Per Ljungman, Rafael de la Cámara	1
9	Murine typhus complicated by sHLH mimicking adult-onset Still's disease 2022 ·La Revue de Médecine Interne ·(unknown), Mathieu Gerfaud‐Valentin, Jean‐Christophe Lega, Ann De Becker, Yvan Jamilloux, P. Sève	3
10	False homozygous HLA genotyping results due to copy number neutral loss of heterozygosity in acquired aplastic anaemia 2017 ·BMJ Case Reports ·(unknown), Ann De Becker, Sonja Verheyden, Christian Demanet	2
11	Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy? breakdown → 2016 ·World Journal of Stem Cells ·Ann De Becker, Ivan Van Riet	377
12	A case report of immunosuppression-related Kaposi’s sarcoma after autologous stem cell transplantation 2016 ·BMC Research Notes ·(unknown), Ann De Becker, Rik Schots	9
13	Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo 2013 ·Acta Pharmacologica Sinica ·Song Xu, Kim De Veirman, Holly Evans, Gaia Santini, Isabelle Vande Broek, Xavier Leleu, Ann De Becker, Ben Van Camp, Peter I. Croucher, Karin Vanderkerken, Ivan Van Riet	50
14	In vitro expanded bone marrow-derived murine (C57Bl/KaLwRij) mesenchymal stem cells can acquire CD34 expression and induce sarcoma formation in vivo 2012 ·Biochemical and Biophysical Research Communications ·Song Xu, Ann De Becker, Hendrik De Raeve, Ben Van Camp, Karin Vanderkerken, Ivan Van Riet	13
15	Early Predictors of Success of Kasai Operation in Children with Biliary Atresia 2007 ·European Journal of Pediatric Surgery ·Burkhard Rodeck, Ann De Becker, Klaus F. Gratz, (unknown)	21
16	Development of a metamodel for large-scale assessment of water and nutrient fluxes - first components and initial tests for the Elbe River basin. 2001 ·Publication Database PIK (Potsdam Institute for Climate Impact Research (PIK)) ·Uwe Haberlandt, Valentina Krysanova, (unknown), Ann De Becker, András Bàrdossy	3
17	Transforming Growth Factor β1 Enhances Platelet Aggregation through a Non-transcriptional Effect on the Fibrinogen Receptor 1999 ·Journal of Biological Chemistry ·James B. Hoying, Moying Yin, Ronald J. Diebold, Ilona Ormsby, Ann De Becker, Thomas Doetschman	40
18	The pathophysiology of alveolar osteonecrosis of the jaw: Anticardiolipin antibodies, thrombophilia, and hypofibrinolysis 1996 ·Journal of Laboratory and Clinical Medicine ·Ralph A. Gruppo, Charles J. Glueck, Robert E. McMahon, Jerry E. Bouquot, Brian Rabinovich, Ann De Becker, Trent Tracy, Ping Wang	60
19	COMPARISON BETWEEN RADIOSURGERY AND STEREOTAXIC FRACTIONATED RADIATION FOR THE TREATMENT OF BRAIN METASTASES 1993 ·UCL Discovery (University College London) ·(unknown), Marwan Hariz, (unknown), (unknown), (unknown), (unknown), F. Eugene Holly, Timothy D. Solberg, Ann De Becker	1
20	Follistatin specifically inhibits pituitary follicle stimulating hormone release invitro 1987 ·Biochemical and Biophysical Research Communications ·Shao‐Yao Ying, Ann De Becker, (unknown), (unknown), Nicholas Ling, Fred Esch, Naoto Ueno, Shunichi Shimasaki, Roger Guillemin	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact